SEC 13F Intelligence

Stephens Investment Management Group LLC / TNDM

Stephens Investment Management Group LLC’s Tandem Diabetes Care Inc Position

Does Stephens Investment Management Group LLC own Tandem Diabetes Care Inc (TNDM)? Not currently — the last reported position was 1.74M shares worth $32M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$32M
Q2 2025
Shares
1.74M
% of Portfolio
+0.43%
Quarters Held
25
position exited

Position History TNDM

Reported value by quarter
Q2 ’19: $9MQ2 ’19Q3 ’19: $29MQ4 ’19: $34MQ1 ’20: $36MQ2 ’20: $61MQ2 ’20Q3 ’20: $68MQ4 ’20: $56MQ1 ’21: $59MQ2 ’21: $76MQ2 ’21Q3 ’21: $98MQ4 ’21: $123MQ1 ’22: $97MQ2 ’22: $50MQ2 ’22Q3 ’22: $47MQ4 ’22: $42MQ1 ’23: $42MQ2 ’23: $25MQ2 ’23Q3 ’23: $21MQ4 ’23: $28MQ1 ’24: $34MQ2 ’24: $46MQ2 ’24Q3 ’24: $54MQ4 ’24: $56MQ1 ’25: $33MQ2 ’25: $32MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20251.74M$32M+0.43%
Q1 20251.71M$33M+0.47%
Q4 20241.56M$56M+0.75%
Q3 20241.27M$54M+0.74%
Q2 20241.14M$46M+0.64%
Q1 2024962.6K$34M+0.45%
Q4 2023962.3K$28M+0.42%
Q3 2023989.1K$21M+0.34%
Q2 20231.01M$25M+0.39%
Q1 20231.03M$42M+0.70%
Q4 2022983.2K$42M+0.77%
Q3 2022979.6K$47M+0.89%
Q2 2022838.4K$50M+0.92%
Q1 2022834.0K$97M+1.42%
Q4 2021819.6K$123M+1.59%
Q3 2021820.3K$98M+1.33%
Q2 2021778.9K$76M+1.04%
Q1 2021671.3K$59M+0.86%
Q4 2020586.5K$56M+0.83%
Q3 2020600.0K$68M+1.20%
Q2 2020619.1K$61M+1.11%
Q1 2020566.0K$36M+0.88%
Q4 2019573.7K$34M+0.64%
Q3 2019498.0K$29M+0.59%
Q2 2019131.9K$9M+0.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Stephens Investment Management Group LLC’s full portfolio or all institutional holders of TNDM.